ducovest

FHI-B:CA:TSX-CI Health Care Giants Covered Call ETF (CAD)

ETF | Others |

Last Closing

CAD 12.61

Change

0.00 (0.00)%

Market Cap

CAD 0.05B

Volume

1.19K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Currency: CAD

Country : Canada

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-11 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

N/A

 CAD 6.19B
XEQT:CA iShares Core Equity Portfolio

N/A

 CAD 6.03B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

N/A

 CAD 5.57B
PHYS-U:CA Sprott Physical Gold Trust

N/A

 CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

N/A

 CAD 4.54B
HXT-U:CA Global X S&P/TSX 60 Index ETF

N/A

 CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

N/A

 CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

N/A

 CAD 3.29B
ZMMK:CA BMO Money Market Fund ETF Seri..

N/A

 CAD 3.24B
NSCB:CA NBI Sustainable Canadian Bond ..

N/A

 CAD 2.78B

ETFs Containing FHI-B:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.94% 91% A- 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.94% 91% A- 79% B-
Trailing 12 Months  
Capital Gain 3.28% 28% F 32% F
Dividend Return 3.47% 62% D 49% F
Total Return 6.75% 31% F 32% F
Trailing 5 Years  
Capital Gain 11.10% 49% F 49% F
Dividend Return 33.83% 89% A- 88% B+
Total Return 44.93% 65% D 59% D-
Average Annual (5 Year Horizon)  
Capital Gain 4.03% 55% F 47% F
Dividend Return 4.52% 56% F 43% F
Total Return 0.49% 74% C 30% F
Risk Return Profile  
Volatility (Standard Deviation) 5.01% 82% B 92% A
Risk Adjusted Return 90.18% 95% A 91% A-
Market Capitalization 0.05B 43% F 23% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.